MPT
Real EstateMedical Properties Trust, Inc. · REIT - Healthcare Facilities · $15B
What is Medical Properties Trust, Inc.?
Medical Properties Trust is a self-advised real estate investment trust focused exclusively on healthcare facilities. Headquartered in Birmingham, Alabama, it acquires and leases hospitals and other clinical properties across the United States and internationally.
MPT operates as a net-lease REIT, meaning it purchases healthcare real estate and leases it back to hospital operators under long-term agreements. Tenants are responsible for most property expenses, which in theory provides predictable rental income. The company earns revenue primarily through lease payments and mortgage interest from hospital and clinical facility operators. Its portfolio spans rehabilitation hospitals, long-term acute care hospitals, community hospitals, ambulatory surgery centers, and medical office buildings.
The company was founded in 2003 and is headquartered in Birmingham, Alabama.
- Net-leased acute care and rehabilitation hospitals
- Long-term acute care hospital properties
- Ambulatory surgery center real estate
- Community and regional hospital facilities
- Medical office buildings and specialty clinical properties
Is MPT a Good Stock to Buy?
UQS Score rates MPT as Poor overall, placing it among the lower-ranked REITs on the platform.
The Growth pillar registers as Neutral, suggesting the business is not in outright decline — a relative bright spot within an otherwise challenged profile. Some investors are drawn to the healthcare real estate theme as a long-term structural story.
Quality, Moat, and Risk all carry Weak labels, reflecting meaningful concerns about balance sheet durability, competitive positioning, and tenant concentration. The Valuation pillar is rated Elevated, meaning the current price does not appear to offer a margin of safety given these headwinds.
Pro members can view the complete pillar breakdown and underlying financial metrics to understand exactly where MPT stands. Sign up free →
Past performance does not guarantee future results. UQS Score is based on fundamental data and is not a buy/sell recommendation.
Does MPT pay dividends?
Yes — Medical Properties Trust, Inc. pays a dividend.
MPT pays a regular dividend, as is common for REITs that are required to distribute most taxable income to shareholders. However, given the Weak Quality and Risk pillar ratings, investors should examine the sustainability of that payout carefully. Dividend history and coverage details are available to Pro members through the full financial metrics view.
When does MPT report earnings?
Medical Properties Trust reports earnings on a quarterly cadence, typical for US-listed REITs.
Quarterly results have reflected ongoing challenges with tenant health and portfolio repositioning. Lease income trends and asset dispositions have been key focal points for the market in recent reporting periods.
For the most recent quarter's results and management commentary, visit Medical Properties Trust's investor relations page directly.
MPT Price History
-62.6% over 5Y
Monthly close, adjusted for stock splits and dividend reinvestment.
What if I invested in Medical Properties Trust, Inc.?
Based on Medical Properties Trust, Inc.'s historical closing prices, adjusted for stock splits and dividend reinvestment. Past performance does not guarantee future results. This is for informational purposes only and is not financial advice.
MPT Long-term Outlook
The fundamental outlook for MPT is cautious. With Risk rated Weak and Valuation rated Elevated, the path to re-rating appears dependent on resolving tenant stress and reducing leverage — neither of which is a near-term certainty. The Neutral Growth label suggests the business is not in freefall, but meaningful improvement across the Quality and Moat pillars would be needed to shift the overall UQS profile.
Growth drivers
- Long-term demand for healthcare real estate as populations age
- Potential portfolio stabilization if distressed tenants are resolved or replaced
- International diversification providing exposure to different healthcare systems
Key risks
- Tenant concentration and operator financial stress weighing on lease reliability
- Elevated valuation leaving limited room for error if fundamentals deteriorate further
- High leverage amplifying sensitivity to rising interest rates and refinancing costs
MPT vs Peers
MPT operates in the REIT space alongside a range of property-focused peers, though its healthcare niche sets it apart from more diversified or industrial-focused competitors.
EastGroup focuses on industrial properties in Sun Belt markets, offering a very different tenant base and property type compared to MPT's hospital-centric portfolio.
CubeSmart operates self-storage facilities, a sector with different demand drivers and tenant risk characteristics than healthcare real estate.
Rexford specializes in Southern California industrial real estate, competing for REIT investor capital with a fundamentally different property and lease structure.
Frequently Asked Questions
What does Medical Properties Trust do?
Medical Properties Trust is a REIT that acquires and net-leases healthcare facilities — primarily hospitals — to operators under long-term agreements. It earns income through lease payments and mortgage interest. Its portfolio spans acute care, rehabilitation, and specialty hospitals, as well as ambulatory surgery centers and medical office buildings.
Does MPT pay dividends?
Yes, MPT pays a regular dividend. As a REIT, it is required to distribute the majority of its taxable income to shareholders. However, given the Weak Quality and Risk pillar ratings, investors should assess dividend sustainability carefully before relying on it for income.
When does MPT report earnings?
Medical Properties Trust reports on a quarterly cadence, consistent with US-listed REITs. For exact dates and the most recent results, check the company's investor relations page directly, as our platform does not publish forward earnings dates.
Is MPT a good stock to buy?
UQS Score rates MPT as Poor, reflecting Weak readings across Quality, Moat, and Risk, alongside an Elevated Valuation. That combination suggests meaningful headwinds. Pro members can access the full pillar breakdown to make a more informed assessment.
Is MPT overvalued?
The UQS Valuation pillar for MPT is rated Elevated, indicating the current price appears high relative to the company's fundamental quality profile. When paired with Weak Quality and Risk scores, an elevated valuation leaves limited margin for error.
How does MPT compare to its competitors?
MPT's healthcare-focused net-lease model differs significantly from industrial and self-storage REITs like EastGroup, CubeSmart, and Rexford. Those peers operate in property types with different demand cycles and tenant risk profiles. MPT's unique exposure to hospital operators introduces sector-specific risks not present in most REIT peers.
What is MPT's market cap bracket?
Medical Properties Trust is classified as a large-cap company. Despite recent share price pressure, it remains one of the larger healthcare REITs by total asset value, though its market capitalization has declined meaningfully from prior peaks.
Who founded Medical Properties Trust?
Medical Properties Trust was founded in 2003 by Edward K. Aldag Jr., R. Steven Hamner, Emmett E. McLean, and William Gilliard McKenzie. The company is headquartered in Birmingham, Alabama, where it has been based since its founding.
Is MPT a long-term quality investment?
As a long-term quality indicator, the UQS Score rates MPT as Poor. Weak scores across Quality, Moat, and Risk suggest the business lacks the durable characteristics typically associated with long-term compounders. The full analysis is available to Pro members.
What is the main competitive advantage of Medical Properties Trust?
MPT's primary differentiator is its specialization in hospital real estate — a niche that requires deep operator relationships and regulatory knowledge. However, the UQS Moat pillar is rated Weak, suggesting this specialization has not translated into a durable competitive advantage as reflected in financial outcomes.
What sector does MPT belong to?
MPT is classified under the Financial Services sector as a real estate investment trust. Within that broad category, it occupies the healthcare REIT niche, focusing specifically on hospital and clinical facility properties rather than residential, industrial, or commercial real estate.
Is MPT a growth stock or value stock?
Based on UQS pillar labels, MPT does not fit cleanly into either category. Growth is rated Neutral — neither a strong growth story nor a deep value play. With Valuation rated Elevated and Quality rated Weak, it currently lacks the characteristics of a traditional value opportunity.
Unlock Full MPT Analysis
Sign in to unlock the detailed analysis behind the UQS Score.
- ✓View the complete five-pillar UQS Score breakdown
- ✓Access underlying financial metrics driving each pillar
- ✓Compare MPT against healthcare REIT peers
- ✓Track score changes as new data is released
- ✓Screen for higher-quality REITs across the sector
Pro Analysis
MPT — Score History
| Date | UQS | Quality | Moat | Growth | Risk | Value | Change |
|---|---|---|---|---|---|---|---|
| May 21, 2026 | 34.3 | 29.4 | 21.0 | 48.8 | 36.4 | 42.9 | +4.7 |
| May 7, 2026 | 29.6 | 29.7 | 21.0 | 48.8 | 14.7 | 33.2 | 0.0 |
| May 4, 2026 | 29.6 | 29.7 | 21.0 | 48.8 | 14.7 | 33.5 | +0.2 |
| May 3, 2026 | 29.4 | 29.7 | 21.0 | 48.1 | 14.7 | 32.8 | 0.0 |
| May 2, 2026 | 29.4 | 29.7 | 21.0 | 48.1 | 14.7 | 32.6 | 0.0 |
| Apr 28, 2026 | 29.4 | 29.7 | 21.0 | 48.2 | 14.7 | 32.6 | -0.3 |
| Apr 19, 2026 | 29.6 | 29.7 | 21.0 | 48.6 | 14.7 | 33.7 | -0.2 |
| Apr 18, 2026 | 29.8 | 29.9 | 21.0 | 48.6 | 14.7 | 34.2 | -1.3 |
| Apr 17, 2026 | 31.1 | 29.9 | 21.0 | 48.6 | 14.7 | 42.8 | +0.2 |
| Apr 12, 2026 | 30.9 | 29.9 | 21.0 | 47.7 | 14.7 | 42.8 | -0.2 |
MPT — Pillar Breakdown
Quality
— 29.5/100 (25%)Medical Properties Trust, Inc. currently shows below-average quality metrics, suggesting challenges with profitability.
Profitability relative to shareholders' equity.
Ability to convert revenue into operating profit.
Bottom-line profit as a share of revenue.
Free cash flow relative to market value.
Growth
— 47.6/100 (20%)Medical Properties Trust, Inc. shows steady but unspectacular growth, typical for mature companies.
Revenue trajectory over the last twelve months.
Compound annual revenue growth rate over 3 years.
Year-over-year earnings per share growth.
Analyst consensus for future revenue growth.
Analyst consensus for future earnings growth.
Risk
— 36.4/100 (15%)Medical Properties Trust, Inc. has some risk factors including moderate leverage or solvency concerns.
Total debt relative to shareholder equity.
Short-term liquidity — ability to pay near-term obligations.
Earnings capacity relative to interest payments.
Valuation
— 42.4/100 (15%)Medical Properties Trust, Inc. has a mixed valuation — some metrics suggest fair value while others appear stretched.
Inverse of forward P/E — higher yield means cheaper stock.
How many years of FCF the market cap represents.
P/E relative to earnings growth — lower is more attractive.
Enterprise value multiple relative to sector median.
Moat
— 21/100 (25%)Medical Properties Trust, Inc. operates in a highly competitive environment with limited sustainable advantages. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for MPT.
Score Composition
Financial Data
More Stock Analysis
How is the MPT UQS Score Calculated?
The UQS (Unified Quality Score) for Medical Properties Trust, Inc. is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.
Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.
Moat (25%) assesses Medical Properties Trust, Inc.'s competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.
Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.
Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.
Valuation (15%) measures whether Medical Properties Trust, Inc. is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.
Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.